全文获取类型
收费全文 | 22361篇 |
免费 | 1529篇 |
国内免费 | 57篇 |
专业分类
耳鼻咽喉 | 164篇 |
儿科学 | 533篇 |
妇产科学 | 358篇 |
基础医学 | 3018篇 |
口腔科学 | 336篇 |
临床医学 | 2757篇 |
内科学 | 3957篇 |
皮肤病学 | 212篇 |
神经病学 | 1956篇 |
特种医学 | 743篇 |
外科学 | 3026篇 |
综合类 | 274篇 |
一般理论 | 30篇 |
预防医学 | 2869篇 |
眼科学 | 442篇 |
药学 | 1714篇 |
中国医学 | 35篇 |
肿瘤学 | 1523篇 |
出版年
2023年 | 145篇 |
2022年 | 260篇 |
2021年 | 513篇 |
2020年 | 324篇 |
2019年 | 468篇 |
2018年 | 551篇 |
2017年 | 410篇 |
2016年 | 452篇 |
2015年 | 608篇 |
2014年 | 783篇 |
2013年 | 1021篇 |
2012年 | 1700篇 |
2011年 | 1736篇 |
2010年 | 1008篇 |
2009年 | 955篇 |
2008年 | 1570篇 |
2007年 | 1715篇 |
2006年 | 1540篇 |
2005年 | 1529篇 |
2004年 | 1510篇 |
2003年 | 1414篇 |
2002年 | 1205篇 |
2001年 | 194篇 |
2000年 | 155篇 |
1999年 | 207篇 |
1998年 | 230篇 |
1997年 | 160篇 |
1996年 | 145篇 |
1995年 | 114篇 |
1994年 | 122篇 |
1993年 | 98篇 |
1992年 | 98篇 |
1991年 | 88篇 |
1990年 | 76篇 |
1989年 | 70篇 |
1988年 | 62篇 |
1987年 | 65篇 |
1986年 | 55篇 |
1985年 | 55篇 |
1984年 | 49篇 |
1983年 | 44篇 |
1982年 | 33篇 |
1981年 | 33篇 |
1980年 | 29篇 |
1979年 | 29篇 |
1978年 | 29篇 |
1977年 | 21篇 |
1976年 | 37篇 |
1974年 | 25篇 |
1973年 | 28篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
Najat C Daw Wayne L Furman Clinton F Stewart Lisa C Iacono Mark Krailo Mark L Bernstein Janet E Dancey Rose Anne Speights Susan M Blaney James M Croop Gregory H Reaman Peter C Adamson 《Journal of clinical oncology》2005,23(25):6172-6180
PURPOSE: Epidermal growth factor receptor is expressed in pediatric malignant solid tumors. We conducted a phase I trial of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in children with refractory solid tumors. PATIENTS AND METHODS: Gefitinib (150, 300, 400, or 500 mg/m2) was administered orally to cohorts of three to six patients once daily continuously until disease progression or significant toxicity. Pharmacokinetic studies were performed during course one (day 1 through 28). RESULTS: Of the 25 enrolled patients, 19 (median age, 15 years) were fully evaluable for toxicity and received 54 courses. Dose-limiting toxicity was rash in two patients treated with 500 mg/m2 and elevated ALT and AST in one patient treated with 400 mg/m2. The maximum-tolerated dose was 400 mg/m2/d. The most frequent non-dose-limiting toxicities were grade 1 or 2 dry skin, anemia, diarrhea, nausea, and vomiting. One patient with Ewing's sarcoma had a partial response. Disease stabilized for 8 to > or = 60 weeks in two patients with Wilms' tumor and two with brainstem glioma (one exophytic). At 400 mg/m2, the median peak gefitinib plasma concentration was 2.2 microg/mL (range, 1.2 to 3.6 microg/mL) and occurred at a median of 2.3 hours (range, 2.0 to 8.3 hours) after drug administration. The median apparent clearance and median half-life were 14.8 L/h/m2 (range, 3.8 to 24.8 L/h/m2) and 11.7 hours (range, 5.6 to 22.8 hours), respectively. Gefitinib systemic exposures were comparable with those associated with antitumor activity in adults. CONCLUSION: Oral gefitinib is well tolerated in children. Development of the drug in combination with cytotoxic chemotherapy will be pursued. 相似文献
12.
Chris Theaker 《Intensive & critical care nursing》2005,21(2):99-109
Central venous catheters (CVCs) are now a routine part of patient management in the intensive care unit (ICU). Over time, a vast amount of literature associated with the use and care of CVCs has accumulated. The purpose of this article is to discuss the literature associated with the care of these devices in a narrative format. Although particular attention is paid to infection control issues, other fundamental areas such as catheter design, dressings, line changing and post insertion management are also discussed. The article goes on to look at the future of CVC design and concludes with an analysis of future developments related to CVCs. 相似文献
13.
Penny Dash Chris Llewellyn Ben Richardson 《医院领导决策参考》2009,(20):29-32
医疗改革是一个世界性难题,各国在医疗改革中都会遇到各自相关的问题。改革艰巨,但并不是不可能完成,本文作者认为,通过关注以分区的方式提供医疗服务可以让医疗改革取得实效。本文从划定分区边界的方式出发,介绍了制定分区医疗战略的五个步骤,并讨论了各医疗系统成功实施各自战略所需采取的措施,这也可以为我国正在推行的医疗改革提供一定的借鉴和参考。 相似文献
14.
15.
16.
17.
Paul Roderick Ruth Davies Chris Jones Terry Feest Steve Smith Ken Farrington 《Nephrology, dialysis, transplantation》2004,19(3):692-701
BACKGROUND: The demand for renal replacement therapy (RRT) in England has risen steadily, although from a lower base than many other developed countries. Predicting the future demand for RRT and the impact of factors such as the acceptance rate, transplant supply and patient survival, is required in order to inform the planning of such services. METHODS: A discrete event simulation model estimates the future demand for RRT in England in 2010 for a range of scenarios. The model uses current prevalence and current and projected future acceptance rates, survival rates and the transitions between modalities to predict future patient numbers. National population and mortality data, published literature and data from the UK Renal Registry and UK Transplant, are used to estimate unmet need for RRT, the impact of changing demography and incidence of Type 2 diabetes, patient haemodialysis (HD) survival and transplant supply. RESULTS: By 2010 the predicted prevalence will have increased from about 30,000 in 2000 to between 42 and 51,000 (900-1000 p.m.p.), an average annual growth of 4.5-6%. Changing transplant supply has a small effect on overall numbers but changes the proportion of patients with functioning graft by up to 8%. Even with an optimistic increase in transplant supply (11% p.a. for 5 years), numbers on HD will continue to rise substantially, especially in the elderly. The factors most influencing future patient numbers are the acceptance rate and dialysis survival. CONCLUSION: This model predicts a substantial growth in the RRT population to 2010 to a rate approaching 1000 p.m.p., particularly in the elderly and those on HD, with a steady state not being reached for at least 25 years. 相似文献
18.
Fetal lung growth in laryngeal atresia and tracheal agenesis 总被引:1,自引:0,他引:1
Three cases of airway obstruction in fetuses born at 21, 32 and 40 weeks gestation are reported. The first had laryngeal atresia, cystic dysplastic kidneys, oligohydramnios and immense fluid-filled lungs. The second had upper tracheal agenesis, a tracheo-oesophageal fistula, a cystic dysplastic horseshoe kidney, oligohydramnios and normal-sized lungs. The third had a pin-hole mucosal tract through an otherwise atretic larynx, normal kidneys, no oligohydramnios and normal-sized lungs. Lung weight:body weight ratios, radial alveolar or radial canalicular counts and point-counting of sections of lungs in cases 1 and 2 show that laryngeal or tracheal obstruction may prevent or reduce the pulmonary hypoplasia associated with renal dysplasia, and in cases 2 and 3, that grossly enlarged, hyperplastic lungs may not be seen unless obstruction is complete. 相似文献
19.
Anita Rachlis Jonathan Angel Marianne Harris Richard Lalonde Fiona Smaill Cecile Tremblay Chris Tsoukas Sharon Walmsley 《The Canadian Journal of Infectious Diseases & Medical Microbiology》2006,17(3):155-163
BACKGROUND AND OBJECTIVES: An eight-member group consisting of Canadian infectious disease and immunology specialists and a family physician with significant experience in HIV management was convened to update existing recommendations, specifically intended for use by Canadian HIV-treating physicians, on the appropriate use of enfuvirtide in HIV/AIDS patients with resistance to other antiretroviral drugs. METHODS: Evidence from the literature and expert opinions of the group members formed the basis of the guidelines. Comments on the draft guidelines were obtained from other physicians across Canada with HIV expertise. The final guidelines represent the group's consensus agreement. RESULTS AND CONCLUSIONS: The recommendations were developed to guide physicians in optimal practices in patient selection for enfuvirtide treatment and subsequent patient management. The issues considered include positive predictors of response to enfuvirtide, stage of disease, optimization of the background regimen, early indicators of enfuvirtide response, and patient education and support. 相似文献
20.